pre-IPO PHARMA

saliogen-therapeutics PRESS RELEASE ARCHIVE

Jul 20, 2022

SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform


Jan 6, 2022

RD Fund Announces Series B Financing Behind SalioGen Therapeutics


Jan 5, 2022

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene Coding™ – A New Category of Genetic Medicine


Jan 5, 2022

Cystic Fibrosis Foundation Announces Investment in SalioGen Therapeutics to Fund Genetic Therapies Research


Nov 10, 2021

SalioGen Therapeutics Appoints Esteemed Industry Veterans to Executive Advisory Board



Nov 10, 2021

SalioGen Therapeutics Appoints Esteemed Industry Veterans to Executive Advisory Board


Jul 28, 2021

SalioGen Therapeutics Strengthens Management with Key Additions to Leadership Team to Advance Its Gene Coding Platform


Mar 1, 2021

SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Support Advancing a Novel Genome Engineering Platform for Non-Viral Gene Therapy


Google Analytics Alternative